
Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible
2015; Springer Science+Business Media; Volume: 95; Issue: 2 Linguagem: Inglês
10.1007/s00277-015-2537-2
ISSN1432-0584
AutoresVânia Hungria, Edvan Crusoé, Ângelo Maiolino, Rosane Bittencourt, Dorotea Fantl, J.F.R. Maciel, Roberto Magalhães, Manuella S.S. Almeida, Priscilla Cury, F Hisgashi, Ana Lucia Peres, Carlos Chiattone,
Tópico(s)Protein Degradation and Inhibitors
Referência(s)